Literature DB >> 22484667

Construction and characterization of a PDCD5 recombinant lentivirus vector and its expression in tumor cells.

Shiyong Wang1, Xue Zeng, Yanping Liu, Chunyan Liang, Hui Zhang, Chang Liu, Weili Du, Zhe Zhang.   

Abstract

The function and mechanism of the programmed cell death 5 (PDCD5) gene is not completely understood, so it is necessary to build a stable and efficient PDCD5 recombinant lentiviral expression vector. The coding region of the PDCD5 gene was PCR amplified from pCMV-SPORT6. Next, the PDCD5 fragment and the pGC-FU vector were digested with the restriction enzyme AgeI and ligated by in-Fusion technology to build the pGC-FU-PDCD5 plasmid. Competent E. coli DH5α cells were transformed and positive clones were identified by PCR. The PCR products were digested and sequenced. After sequencing, positive clones were selected to grow and propagate. The pGC-FU-PDCD5 plasmid DNA was purified and mixed with the pHelper1.0 and pHelper2.0 packaging plasmids. They were co-transfected into 293T cells. The viral titer was measured by real-time PCR. The expression of GFP and PDCD5 was detected by both Western blotting and fluorescence microscopy. Additionally, the A498, ACHN, HCT116 and LoVo tumor cell lines were transfected with the virus supernatant, and PDCD5 expression was detected in these cells. The constructed pGC-FU-PDCD5 plasmid contained the correct PDCD5 gene sequence. Strong green fluorescence in both the cytoplasm and cell membrane was observed following transfection with purified pGC-FU-PDCD5 into 293T cells. The transfection rate was greater than 95%, and the expression of the PDCD5-GFP fusion protein was confirmed by Western blotting. The titer of the recombinant PDCD5 lentiviral condensed supernatant was measured to be 2 x 10(9) Tu/ml. The transfection efficiencies of A498, ACHN and HCT116 cells were greater than 90%. However, transfection efficiency of LoVo cells was lower but still greater than 70%. The PDCD5-GFP fusion protein was stable in these transfected tumor cells, as detected by Western blotting. In conclusion, a PDCD5 recombinant lentiviral vector was successfully constructed, and high expression of the plasmid was observed in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484667     DOI: 10.3892/or.2012.1756

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Crystal structure of the programmed cell death 5 protein from Sulfolobus solfataricus.

Authors:  Kuan Fu Lin; Jia Yuan Hsu; Dong Lin Hsieh; Meng Ju Tsai; Ching Hui Yeh; Chin Yu Chen
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-01-23       Impact factor: 1.056

2.  Construction and expression of a lentivirus expression vector carrying the VEGF165-EGFP fusion gene in breast cancer MCF-7 cells.

Authors:  Minna Luo; Huan Huang; Lei Hou; Shan Shao; Shangke Huang; Xinhan Zhao
Journal:  Oncol Lett       Date:  2017-01-17       Impact factor: 2.967

3.  HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer.

Authors:  Jie Xu; Qingtao Meng; Hao Sun; Xinwei Zhang; Jun Yun; Bin Li; Shenshen Wu; Xiaobo Li; Hongbao Yang; Haitao Zhu; Michael Aschner; Michela Relucenti; Giuseppe Familiari; Rui Chen
Journal:  Cell Death Dis       Date:  2021-11-27       Impact factor: 8.469

4.  CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma.

Authors:  Quan Liu; Dahua Fan; Dickson Adah; Zhengzhi Wu; Renyan Liu; Qiao-Ting Yan; Yue Zhang; Zhi-Yong Du; Dou Wang; Yan Li; Shi-Yun Bao; Li-Ping Liu
Journal:  Oncol Rep       Date:  2018-08-23       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.